StockData
Vericel Corp logo

Vericel Corp (VCEL) stock

VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30329% above fair value
$57.88+0.40 (+0.70%)

Close on Nov 17, 2026Market cap $2.96BP/E 137.8Yield –

Vericel total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Vericel's total debt was $13.18M at Sep 30, 2018. For fiscal 2017 it was $16.89M, up 81.2% from the year before. The highest annual figure on record is $16.89M in fiscal 2017.

Annual total debt

PeriodPeriod endValueChange
FY2017Dec 31, 2017$16.89M+81.2%
FY2016Dec 31, 2016$9.32M+13023.9%
FY2015Dec 31, 2015$71.00K-34.9%
FY2014Dec 31, 2014$109.00K+808.3%
FY2013Dec 31, 2013$12.00K-70.0%
FY2012Dec 31, 2012$40.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2018Sep 30, 2018$13.18M+78.1%
Q2 FY2018Jun 30, 2018$14.42M+79.3%
Q1 FY2018Mar 31, 2018$15.65M+80.3%
Q4 FY2017Dec 31, 2017$16.89M+81.2%
Q3 FY2017Sep 30, 2017$7.40M+17519.0%
Q2 FY2017Jun 30, 2017$8.04M–
Q1 FY2017Mar 31, 2017$8.68M–
Q4 FY2016Dec 31, 2016$9.32M–
Q3 FY2016Sep 30, 2016$42.00K–

More Vericel figures

See a number that looks wrong?